Neoplasms, Gastrointestinal Tract
4 clinical trials · Condition
◉ Watch Neoplasms, Gastrointestinal Tract
| Record | Firm | Date |
|---|---|---|
| LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib (NCT00680901) | Novartis Pharmaceuticals | 2008-06-04 |
| Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib (NCT00526669) | GlaxoSmithKline | 2008-03-01 |
| Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer (NCT00486954) | GlaxoSmithKline | 2007-07-01 |
| Study of GSK1363089 in Metastatic Gastric Cancer (NCT00725712) | GlaxoSmithKline | 2007-03-31 |
Track Neoplasms, Gastrointestinal Tract automatically
Every clearance here is in the API, with alerts when new ones post.